Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris

NCT00098358 is registered in ClinicalTrials.gov with Critical Therapeutics as lead sponsor.

NCT NCT00098358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00098358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Proof of Concept Study of Zileuton IR in Patients With Moderate to Severe Facial Acne Vulgaris
Lead sponsor
Critical Therapeutics
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2004
Completion date
May 31, 2005
Enrollment
90
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris